Innovative Research Award
Peng-Yuan Wang – Wenzhou Medical University
Peng-Yuan Wang’s ORCID record documents research spanning biomaterials, cellular microenvironments, stem-cell behaviour, surface engineering and biomedical applications. His listed publications provide a basis for examining interdisciplinary research contributions relevant to translational science and precision-oriented biomedical investigation. The Innovative Research Award article presents a scholarly overview of this documented research profile, while distinguishing publication evidence from award assessment. [1]
Abstract
This article reviews selected research recorded under Peng-Yuan Wang’s ORCID profile, focusing on biomaterial interfaces, engineered cell environments, stem-cell responses and biomedical models. The listed works illustrate approaches that connect material properties with biological behaviour, including surface nanotopographies, colloidal crystal patterns and engineered tumour systems. These themes may inform future research in precision medicine, although the supplied record alone does not establish a direct clinical outcome or confirm an award decision. [2]
Keywords
Peng-Yuan Wang; Innovative Research Award; precision medicine; biomaterials; stem-cell engineering; cellular microenvironment; nanostructured surfaces; tumour models; biomedical research; translational science.
Introduction
Interdisciplinary biomedical research examines how engineered materials, cellular signals and tissue environments influence biological processes. Wang’s recorded publications include studies of cell attachment, differentiation, stem-cell culture and tumour-related systems. Such research areas are relevant to the development of experimental platforms that investigate disease biology and potential therapeutic strategies. Publication metadata supports describing these themes, but detailed conclusions should be drawn from the full articles rather than titles alone. [3]
Research Profile
The supplied ORCID export lists research articles across biomaterials, biointerfaces, stem-cell science and biomedical engineering. It records the ORCID identifier 0000-0001-7965-2914 and Scopus Author ID 55973775800, enabling readers to consult the researcher’s publication records directly. The document provided does not independently verify the institution or the supplied citation and h-index totals; those metrics should be checked against the current Scopus profile before formal publication. [1]
Research Contributions
Recorded studies address how engineered surface features affect cell behaviour and how biomaterial platforms can support biological models. Examples include work on colloidal crystal systems for induced pluripotent stem cells, nanotopographies for mesenchymal stem cells, and engineered matrices for tumoroid generation. These publications demonstrate a recurring interest in controlling the cellular microenvironment through material design. Their specific experimental findings and clinical significance require assessment of each article’s full text. [4]
Publications
Selected works in the supplied ORCID record include “Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells,” “Modulation of human mesenchymal and pluripotent stem cells using surface nanotopographies and surface-immobilised bioactive signals: A review,” and “Artificial tumor matrices and bioengineered tools for tumoroid generation.” The record also lists “Human platelet lysate enhances small lipid droplet accumulation of human MSCs through MAPK phosphorylation” and “Tumor-Mimetic Microenvironment Primes Cancer Stemness and Drug Resistance through Nucleoskeleton-Mediated Chromatin Remodeling.” [2][3][4][5]
Research Impact
Potential significance lies in the use of engineered materials and cellular models to investigate biological responses under controlled conditions. Tumour models and drug-sensitivity platforms may be relevant to precision-oriented research, while stem-cell studies can inform regenerative and tissue-engineering investigations. The supplied bibliographic record establishes publication activity, not proof of clinical adoption, treatment efficacy or individual contribution to every result. Such claims require careful review of article methods, authorship and subsequent evidence. [5]
Award Suitability
The documented breadth of work across biomaterials, cell engineering and biomedical models provides relevant material for consideration under an Innovative Research Award. A fair assessment should examine originality, methodological quality, reproducibility, contribution to collaborative publications and demonstrated research influence. Citation counts and h-index can provide context but should not substitute for expert review. This article describes potential alignment with the award theme and does not represent an official decision by the International Top Pharmaceutical Awards. [1]
Conclusion
Peng-Yuan Wang’s indexed research record presents a multidisciplinary profile connecting engineered biomaterials, cell responses and biomedical applications. The selected publications offer identifiable directions for further scholarly review, including stem-cell culture systems, tumour modelling and microenvironment engineering. Verification of current metrics, affiliation and award status remains necessary for formal recognition materials. Readers can consult the linked ORCID, Scopus and DOI records to examine the underlying evidence and publication details.[4]
External Links
References
- ORCID. (n.d.). Peng-Yuan Wang: Researcher record and works. ORCID. https://orcid.org/0000-0001-7965-2914
- Wang, P.-Y., et al. (2016). Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs). Scientific Reports. DOI: 10.1038/srep36845
- Wang, P.-Y., Thissen, H., and Kingshott, P. (2016). Modulation of human multipotent and pluripotent stem cells using surface nanotopographies and surface-immobilised bioactive signals: A review. Acta Biomaterialia. DOI: 10.1016/j.actbio.2016.08.054
- Liu, Y.-C., et al. (2024). Artificial tumor matrices and bioengineered tools for tumoroid generation. Biofabrication. DOI: 10.1088/1758-5090/ad2534
- Du, P., et al. (2024). Human platelet lysate enhances small lipid droplet accumulation of human MSCs through MAPK phosphorylation. Stem Cell Research & Therapy. DOI: 10.1186/s13287-024-04085-5